Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) Return on Sales (2017 - 2025)

Neuronetics (STIM) has disclosed Return on Sales for 9 consecutive years, with 0.18% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 44.0% to 0.18% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.26% through Dec 2025, up 30.0% year-over-year, with the annual reading at 0.27% for FY2025, 29.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.18% at Neuronetics, up from 0.25% in the prior quarter.
  • The five-year high for Return on Sales was 0.18% in Q4 2025, with the low at 0.78% in Q1 2022.
  • Average Return on Sales over 5 years is 0.5%, with a median of 0.51% recorded in 2021.
  • The sharpest move saw Return on Sales tumbled -32bps in 2021, then skyrocketed 44bps in 2025.
  • Over 5 years, Return on Sales stood at 0.53% in 2021, then rose by 9bps to 0.49% in 2022, then soared by 36bps to 0.31% in 2023, then tumbled by -100bps to 0.62% in 2024, then skyrocketed by 71bps to 0.18% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.18%, 0.25%, and 0.26% for Q4 2025, Q3 2025, and Q2 2025 respectively.